Related Experiment Videos
Correlation plasma levels, NSAID and therapeutic response.
Clinical Rheumatology
|June 1, 1985
Summary
Monitoring nonsteroidal anti-inflammatory drug (NSAID) plasma levels can help manage side effects and track treatment. However, strong correlations between NSAID levels and clinical effects are rare, especially in rheumatic diseases.
Area of Science:
- Pharmacology
- Clinical Chemistry
Background:
- Regular monitoring of nonsteroidal anti-inflammatory drug (NSAID) plasma levels is suggested for managing side effects and ensuring patient compliance.
- Establishing a link between drug concentration and clinical outcomes requires specific prerequisites, often unmet for NSAIDs.
Purpose of the Study:
- To explore the utility of regular NSAID plasma level monitoring.
- To assess the correlation between NSAID plasma concentrations and their therapeutic and adverse effects.
Main Methods:
- Review of existing literature on NSAID pharmacokinetics and pharmacodynamics.
- Analysis of studies correlating drug plasma levels with clinical effects and side effects.
Main Results:
- Evidence for a strong correlation between NSAID plasma levels and clinical effects is scarce.
- The best correlations were observed with salicylates, with established therapeutic ranges for rheumatoid arthritis.
- Correlations for side effects like tinnitus and salicylism were also noted, but with significant individual variability and overlap between therapeutic and toxic levels.
Conclusions:
- NSAID plasma level monitoring has potential benefits but lacks robust evidence of correlation with clinical outcomes for most NSAIDs.
- Salicylates show the most promising correlation, but individual variations persist.
- Further research is needed to establish reliable monitoring strategies for NSAIDs in managing rheumatic diseases.